# SYNTHESIS Multi-Persona Review (Round 3): Overfitting & Stability Integration

This review evaluates the potential integration of optimism-correction and cross-validation techniques (inspired by the `metaoverfit` package) into the SYNTHESIS framework.

---

## 1. The Methodological Purist (Academic Statistician)
**Focus:** The validity of R²-heterogeneity in non-standard models.

> "The `metaoverfit` approach to calculating cross-validated R² for heterogeneity (R²_het) is excellent for standard meta-regression. However, SYNTHESIS is a 7-layer non-linear weighting system. 
>
> **The Critique:** Simply calculating R²_het might not be enough. We need a 'Stability Index'. If we use Leave-One-Out Cross-Validation (LOOCV) on SYNTHESIS, we shouldn't just look at how much the mean changes, but how much the 'Density Map' (Layer 2) shifts when one study is removed. If the map is unstable, the model is over-relying on a specific study cluster—this is a deeper form of overfitting than just R² inflation."

---

## 2. The Clinical Statistician (Trialist)
**Focus:** Sample size and reliability.

> "The `check_overfitting` function in the NHS metaoverfit code uses a study-to-parameter ratio (k/p). This is vital. SYNTHESIS is a complex model, and running it on only 10 or 12 studies (as seen in our 'Stress Test') is risky.
>
> **The Critique:** I strongly support adding a 'Reliability Shield' to SYNTHESIS. If a user tries to run the 7-layer model on fewer than 15 studies, the system should automatically trigger a 'Small-Sample Optimism' warning, similar to the `sample_size_recommendation` in the other package. We should ensure SYNTHESIS doesn't provide a 'Corrected Trajectory' (Layer 6) that is actually just noise-fitting."

---

## 3. The Software Architect (R Developer)
**Focus:** Modularity and Performance.

> "Integrating Cross-Validation (CV) into SYNTHESIS will increase computational load by a factor of *k*.
>
> **The Critique:** We should implement the CV layers as 'Optional Diagnostics'. The core `synthesis_meta()` should remain fast, but a secondary function, `synthesis_stability()`, could run the LOOCV and Bootstrap checks. This keeps the package modular. I also recommend borrowing the `ggplot2` diagnostic style from `metaoverfit` to visualize 'Optimism' (the gap between apparent and corrected results)."

---

## 4. The Regulatory Lead (NICE/Evidence Manager)
**Focus:** Transparency and "Optimism Reporting."

> "Regulators are increasingly wary of 'p-hacking' through complex weighting. 
>
> **The Critique:** If we add the 'Corrected R²' from `metaoverfit`, we must present it as the 'Honest Yield'. It tells us: 'The moderators explain 60% of heterogeneity in this sample, but only 40% is likely to hold in the real world.' Adding this 'Optimism Report' to the SYNTHESIS output would make it the most transparent meta-analysis tool in the NHS portfolio."

---

## Final Synthesis Recommendation (Phase 3)
1.  **New Module**: Create `synthesis_stability()` to perform Leave-One-Out Cross-Validation.
2.  **Metric**: Calculate a 'Corrected Yield' (Optimism-corrected R² equivalent) to show how much the 7-layer filtering actually improves the signal.
3.  **Safety**: Add a 'Heuristic Risk' check based on the $k/p$ ratio to warn against complex trajectory fitting in small datasets.

---
*Review conducted by Gemini CLI Multi-Persona Protocol, Feb 2026.*
